Recherche
-
Trans-ethnic association study of blood pressure determinants in over 750,000 individuals
(Nature Genetics. vol. 51, n° 1, pp. 51-62, 2019-01)Article de revueLibre accès -
Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial
(PLoS ONE. vol. 14, n° 1, pp. e0209911, 2019)Article de revueLibre accès -
Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn's-Like Microbiota Disturbances
(J Clin Med. vol. 8, n° 5, 2019-05-10)Article de revueLibre accès -
Health administrative data enrichment using cohort information: Comparative evaluation of methods by simulation and application to real data.
(PLoS ONE. vol. 14, n° 1, pp. e0211118, 2019-01-01)Article de revueLibre accès -
Health administrative data enrichment using cohort information: Comparative evaluation of methods by simulation and application to real data
(PLoS ONE. vol. 14, n° 1, pp. e0211118, 2019-01-31)Article de revueLibre accès -
OPTIMIR, a novel algorithm for integrating available genome-wide genotype data into miRNA sequence alignment analysis
(RNA (New York, N.Y.). vol. 25, n° 6, pp. 657-668, 2019-06)Article de revueLibre accès -
Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization study
(British Journal of Clinical Pharmacology. vol. 85, n° 11, pp. 2524-2539, 2019-11)Article de revueLibre accès -
Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort
(British Journal of Cancer. vol. 121, n° 12, pp. 1001-1008, 2019-12)Article de revueLibre accès -
A large-scale exome array analysis of venous thromboembolism
(Genetic epidemiology. vol. 43, n° 4, pp. 449-457, 2019-06)Article de revueLibre accès -
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies
(University of Chicago Press Books, 2019)Chapitre d'ouvrageLibre accès